Polyunsaturated fatty acids in heart failure: Should we give more and give earlier?

Journal of the American College of Cardiology

Volumn 57, Issue 7, 2011, Pages 880-883

  Tang, W H Wilson ^a   Samara, Michael A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

functional capacity; heart failure; n 3 PUFAs; nonischemic cardiomyopathy; NYHA functional class

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; ROSUVASTATIN;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CORONARY HEMODYNAMICS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HEART FAILURE; HUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 79851509082     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.014     Document Type: Editorial

References (16)

1. G.C. Fonarow, C.W. Yancy, and N.M. Albert Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
2. H.O. Bang, and J. Dyerberg Plasma lipids and lipoproteins in Greenlandic west coast Eskimos Acta Med Scand 192 1972 85 94
3. C.J. Lavie, R.V. Milani, M.R. Mehra, and H.O. Ventura Omega-3 polyunsaturated fatty acids and cardiovascular diseases J Am Coll Cardiol 54 2009 585 594
4. K.K. Witte, and A.L. Clark Marine polyunsaturated fatty acids in heart failure: are the theoretical benefits matched by the clinical data? Pol Arch Med Wewn 119 2009 162 169
5. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
6. A. Macchia, G. Levantesi, M.G. Franzosi GISSI-Prevenzione Investigators Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids Eur J Heart Fail 7 2005 904 909 (Pubitemid 41125915)
7. D. Mozaffarian, C.L. Bryson, R.N. Lemaitre, and D.S. Siscovick Fish intake and risk of incident heart failure J Am Coll Cardiol 45 2005 2015 2021 (Pubitemid 40814125)
8. S.C. Dijkstra, I.A. Brouwer, and F.J. van Rooij Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study Eur J Heart Fail 11 2009 922 928
9. K. Yamagishi, H. Iso, and C. Date Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) study J Am Coll Cardiol 52 2008 988 996
10. K. Yamagishi, J.A. Nettleton, and A.R. Folsom Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 156 2008 965 974
11. The GISSI-HF investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial Lancet 372 2008 1223 1230
12. S. Ghio, L. Scelsi, R. Latini GISSI-HF investigators Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial Eur J Heart Fail 12 2010 1345 1353
13. S. Nodari, M. Triggiani, and U. Campia Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy J Am Coll Cardiol 57 2011 870 879
14. A. Ahmed, R.M. Allman, and G.C. Fonarow Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study J Card Fail 14 2008 211 218 (Pubitemid 351434595)
15. W.H. Tang, and G.S. Francis Statin treatment for patients with heart failure Nat Rev Cardiol 7 2010 249 255
16. R. Røysland, S. Masson, and T. Omland Prognostic value of osteoprotegerin in chronic heart failure: the GISSI-HF trial Am Heart J 160 2010 286 293